Grant: Engage Grants Program
University of Manitoba
$25,000.00
Nanoparticle Based Cell Selective Modulation of SSAT1 Expression
EF 2017-18
Résumé
The regulation of polyamine levels in cells is highly regulated and dependent upon both the synthesis andcatabolism processes at work within the cell. As enzymes involved in both the synthesis (ornithinedecarboxylase) and catabolism (spermine/spermidine actyl transferase 1; SSAT1) of polyamines are known tobe altered under pathological conditions such as cancer, modulation of enzyme expression/activity has beenidentified as a potential therapeutic target for cancer. However, fundamental obstacles impede advancementsin this area. As polyamine concentrations within the cell drive many important biological functions, a keylimitation to scientific advancement of this field has been the inability to SELECTIVELY alter the expressionof key enzymes in polyamine metabolism within DISCRETE cellular populations. A potential solution to thisproblem is the use of nanoparticle systems to delivery the desired compounds to selected cell types. Byoptimizing lipid and polymer based coatings and attaching targeting vectors to the surface of the nanoparticle itis possible to ""tune"" the nanoparticle to interact with selected cells while minimizing interactions withoff-target cells. The objective of this research application is to design, characterize and provide initialproof-of-concept for targeted alteration of SSAT1 expression within a selected cell population. By optimizingthe nanoparticle surface through lipid and polymer composition, as well as through the attachment of celltargeting vectors, it is hypothesized that a more effective and cell selective approach to modulation of enzymeexpression can be achieved. Rationale for this particular enzyme and cell is based on the over-expression ofSSAT1 observed in brain tumors and recent studies suggesting alterations in SSAT1 expression in GB couldinfluence cell survival. The focus of this project is to identify survival advantages of SSAT1 in GB cells anddevelop a cellular ""tuned"" nanoparticle based delivery system tailored to modulate SSAT1 expression.Ultimately the goal is to optimize nanoparticle delivery to select tumor cells while avoiding delivery to normalcell populations.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
519893-2017
Name nom
Miller, Donald
Department département
Pharmacology and Therapeutics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
6404
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Pharmacology
Research subject fr
Pharmacologie
Partie
1
Nb partie
1
Application title
Nanoparticle Based Cell Selective Modulation of SSAT1 Expression
Keyword
NSERC
Application summary
The regulation of polyamine levels in cells is highly regulated and dependent upon both the synthesis andcatabolism processes at work within the cell. As enzymes involved in both the synthesis (ornithinedecarboxylase) and catabolism (spermine/spermidine actyl transferase 1; SSAT1) of polyamines are known tobe altered under pathological conditions such as cancer, modulation of enzyme expression/activity has beenidentified as a potential therapeutic target for cancer. However, fundamental obstacles impede advancementsin this area. As polyamine concentrations within the cell drive many important biological functions, a keylimitation to scientific advancement of this field has been the inability to SELECTIVELY alter the expressionof key enzymes in polyamine metabolism within DISCRETE cellular populations. A potential solution to thisproblem is the use of nanoparticle systems to delivery the desired compounds to selected cell types. Byoptimizing lipid and polymer based coatings and attaching targeting vectors to the surface of the nanoparticle itis possible to ""tune"" the nanoparticle to interact with selected cells while minimizing interactions withoff-target cells. The objective of this research application is to design, characterize and provide initialproof-of-concept for targeted alteration of SSAT1 expression within a selected cell population. By optimizingthe nanoparticle surface through lipid and polymer composition, as well as through the attachment of celltargeting vectors, it is hypothesized that a more effective and cell selective approach to modulation of enzymeexpression can be achieved. Rationale for this particular enzyme and cell is based on the over-expression ofSSAT1 observed in brain tumors and recent studies suggesting alterations in SSAT1 expression in GB couldinfluence cell survival. The focus of this project is to identify survival advantages of SSAT1 in GB cells anddevelop a cellular ""tuned"" nanoparticle based delivery system tailored to modulate SSAT1 expression.Ultimately the goal is to optimize nanoparticle delivery to select tumor cells while avoiding delivery to normalcell populations.